R.H. Investment Group LLC Makes New Investment in UnitedHealth Group Incorporated (NYSE:UNH)

R.H. Investment Group LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 6,885 shares of the healthcare conglomerate’s stock, valued at approximately $3,483,000. UnitedHealth Group makes up 3.3% of R.H. Investment Group LLC’s investment portfolio, making the stock its 20th largest holding.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. WINTON GROUP Ltd bought a new position in UnitedHealth Group during the 2nd quarter valued at about $228,000. Renaissance Technologies LLC purchased a new stake in UnitedHealth Group in the second quarter worth approximately $36,323,000. Primecap Management Co. CA raised its stake in UnitedHealth Group by 3.9% during the 2nd quarter. Primecap Management Co. CA now owns 116,464 shares of the healthcare conglomerate’s stock valued at $59,310,000 after buying an additional 4,350 shares during the last quarter. Lumbard & Kellner LLC bought a new stake in shares of UnitedHealth Group in the second quarter worth $1,019,000. Finally, Financial & Tax Architects LLC bought a new position in UnitedHealth Group in the second quarter valued at about $442,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH opened at $543.21 on Thursday. The business’s 50 day simple moving average is $554.45 and its 200-day simple moving average is $563.12. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market capitalization of $499.91 billion, a price-to-earnings ratio of 35.39, a price-to-earnings-growth ratio of 1.53 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $6.56 EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

Analysts Set New Price Targets

UNH has been the topic of several recent research reports. UBS Group lowered their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Barclays raised their price objective on UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 27th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. Two equities research analysts have rated the stock with a hold rating, eighteen have given a buy rating and three have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $626.79.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.